Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Basic research into Parkinson’s


Parkinson’s disease was first described in 1817 by the London physician James Parkinson. A great amount of research has been carried out since that time but the fundamental causes of the disease remain unresolved. Some time ago now researchers found that a neurotransmitter, dopamine, played a key role in this illness. This is why the majority of treatments used today to counter Parkinson’s increase the level of dopamine in the brain exciting the receptors of this neurotransmitter.

Animal models

Parkinson’s disease affects certain concrete cerebral nuclei in the human brain. These nuclei are the striated and the dark matter, nuclei which are related to the motor system. Parkinson’s disease specifically affects those neurones located between these cerebral nuclei.

So, when animals are used as models in order to analyse the illness, rats for example, lesions appear precisely at the location of these cerebral nuclei. The procedure involves introducing a toxic substance into specific co-ordinates of the rat’s brain, but only into one hemisphere thereof, the other remaining as a control or reference. In other words, so that the Parkinson’s is generated solely on one side of the animal’s brain.

Once the animal has recovered from the operation, after approximately one month, the analyses can begin. On the one hand, the behaviour of the animal is studied and analysed – the visible, external effects and, on the other, the effects of medication. In order to analyse the effects of the medication habitually used to treat the ailment, these medicines are administered and subsequently the electro-physiological activity of the brain is measured, i.e. the activity of the neurones. In this way it is intended to discover the medication most suitable to stop the progress of the disease.

Mild Parkinson’s

By the time Parkinson’s symptoms appear in humans, cerebral lesions are quite serious and the disease passed the point of no return. However, apparently, if the disease is managed to be detected at the early stages and applying a neurone protection treatment, the illness can be halted.

But, in this case, the validity of the medicines used presently is called into question. For example, the effects that the currently most commonly used treatment, levodopa. That is, it is not clear whether levodopa administered in the early stages of Parkinson’s is neuroprotector or neurotoxic. To this end, in order to analyse, amongst other factors, the effects that levodopa produce in the early stages of Parkinson’s, a model of mild Parkinson’s has been developed at the Leioa campus of the University of the Basque Country.

Obtaining rats with mild Parkinson’s is no easy task, given that the exact dose of the toxic substance has to be injected into the animal brain. Once a rat with mild Parkinson’s has been obtained, the usual medicines are administered and the animal monitored to see if there is a differentiated evolution in the disease or not. Thus, according the Leioa investigation, the effect of the medication is totally different depending if the rat is healthy, if it has mild Parkinson’s, or if the disease is advanced.

So, definite conclusions have yet to drawn, Moreover, in the case of Parkinson’s, soon we will have to start dealing with gene therapy or therapeutic cloning, given that these are the future paths to follow in order to counter the disease, according to the experts.

Garazi Andonegi | Basque research
Further information:

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Space observation with radar to secure Germany's space infrastructure

Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.

The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

New solar solutions for sustainable buildings and cities

23.03.2018 | Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

Latest News

For graphite pellets, just add elbow grease

23.03.2018 | Materials Sciences

Unique communication strategy discovered in stem cell pathway controlling plant growth

23.03.2018 | Agricultural and Forestry Science

Sharpening the X-ray view of the nanocosm

23.03.2018 | Physics and Astronomy

Science & Research
Overview of more VideoLinks >>>